Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin

B B. Gowen
D F. Smee
M H. Wong
J O. Hall
K H. Jung
K W. Bailey
J R. Stevens
Y Furuta
John D. Morrey, Utah State University